Deciphera Pharmaceuticals (DCPH) clinical trials: pipeline and status changes, no readout expected in the next 12 months
$DCPH · Deciphera Pharmaceuticals, LLCTrials that could report in the next 12 months: 0BiopharmaCTG
Catalyst timeline
No upcoming catalysts tracked for DCPH. Estimated readout windows appear automatically as tracked trials approach their registered completion dates.
Pipeline
| Program | Phase | Status | Primary completion | Trial |
|---|---|---|---|---|
| Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and T… | Phase 1 | Active Not Recruitingenrolled, still running | NCT03069469 | |
| A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Ther… | Phase 1 | Recruitingstill enrolling patients | NCT05957367 | |
| A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With… | Phase 3 | Active Not Recruitingenrolled, still running | NCT05734105 | |
| A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Ve… | Phase 2 | Recruitingstill enrolling patients | NCT06619561 | |
| A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tum… | Phase 1 | Recruitingstill enrolling patients | NCT06630234 | |
| Study of DCC-2812 in Participants With Advanced Genitourinary Cancers | Phase 1 | Recruitingstill enrolling patients | NCT06966024 | |
| Evaluate the Effect of Vimseltinib on P-glycoprotein (P-gp) Inhibition… | Phase 1 | Not Yet Recruitingnot open yet | NCT07744802 |
Status-change history
Every ClinicalTrials.gov change recorded for DCPH's trials — a running history no other tracker shows.
No status changes detected yet for this ticker.
Frequently asked
When is DCPH's next PDUFA date?
No disclosed PDUFA date is currently tracked for this ticker.
What phase is DCPH's lead program in?
Phase 3 — active not recruiting.
Where does this data come from?
ClinicalTrials.gov v2 API (trial status + diffs) and company 8-K/press-release disclosures (PDUFA dates). Every number links to its source.